Current and historical daily PE Ratio for Innoviva Inc (
) from 2004 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Innoviva stock (INVA) PE ratio as of Apr 24 2024 is 6.95.
More Details
Innoviva Inc (INVA) PE Ratio (TTM) Chart
Innoviva Inc (INVA) PE Ratio (TTM) Historical Data
View and export this data going back to 2004. Start your Free Trial
Total 1214
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Innoviva PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-25 | 7.0 | 2024-02-20 | 7.3 |
| 2024-04-23 | 7.0 | 2024-02-16 | 7.3 |
| 2024-04-22 | 6.8 | 2024-02-15 | 7.3 |
| 2024-04-19 | 6.9 | 2024-02-14 | 7.3 |
| 2024-04-18 | 6.7 | 2024-02-13 | 7.1 |
| 2024-04-17 | 6.6 | 2024-02-12 | 7.2 |
| 2024-04-16 | 6.6 | 2024-02-09 | 7.2 |
| 2024-04-15 | 6.6 | 2024-02-08 | 7.2 |
| 2024-04-12 | 6.7 | 2024-02-07 | 7.1 |
| 2024-04-11 | 6.8 | 2024-02-06 | 7.3 |
| 2024-04-10 | 6.7 | 2024-02-05 | 7.3 |
| 2024-04-09 | 6.8 | 2024-02-02 | 7.3 |
| 2024-04-08 | 6.8 | 2024-02-01 | 7.5 |
| 2024-04-05 | 6.7 | 2024-01-31 | 7.4 |
| 2024-04-04 | 6.7 | 2024-01-30 | 7.6 |
| 2024-04-03 | 6.8 | 2024-01-29 | 7.7 |
| 2024-04-02 | 6.8 | 2024-01-26 | 7.5 |
| 2024-04-01 | 7.0 | 2024-01-25 | 7.6 |
| 2024-03-28 | 7.0 | 2024-01-24 | 7.5 |
| 2024-03-27 | 7.0 | 2024-01-23 | 7.7 |
| 2024-03-26 | 6.9 | 2024-01-22 | 7.7 |
| 2024-03-25 | 6.9 | 2024-01-19 | 7.5 |
| 2024-03-22 | 6.9 | 2024-01-18 | 7.4 |
| 2024-03-21 | 6.9 | 2024-01-17 | 7.4 |
| 2024-03-20 | 6.8 | 2024-01-16 | 7.5 |
| 2024-03-19 | 6.7 | 2024-01-12 | 7.5 |
| 2024-03-18 | 6.7 | 2024-01-11 | 7.5 |
| 2024-03-15 | 6.8 | 2024-01-10 | 7.6 |
| 2024-03-14 | 6.8 | 2024-01-09 | 7.5 |
| 2024-03-13 | 6.8 | 2024-01-08 | 7.6 |
| 2024-03-12 | 6.8 | 2024-01-05 | 7.6 |
| 2024-03-11 | 6.8 | 2024-01-04 | 7.7 |
| 2024-03-08 | 6.8 | 2024-01-03 | 7.5 |
| 2024-03-07 | 6.9 | 2024-01-02 | 7.5 |
| 2024-03-06 | 7.0 | 2023-12-29 | 7.4 |
| 2024-03-05 | 6.8 | 2023-12-28 | 7.4 |
| 2024-03-04 | 7.0 | 2023-12-27 | 37.0 |
| 2024-03-01 | 7.0 | 2023-12-26 | 37.0 |
| 2024-02-29 | 7.0 | 2023-12-22 | 36.9 |
| 2024-02-28 | 7.0 | 2023-12-21 | 36.8 |
| 2024-02-27 | 7.0 | 2023-12-20 | 36.3 |
| 2024-02-26 | 7.1 | 2023-12-19 | 36.2 |
| 2024-02-23 | 7.1 | 2023-12-18 | 35.6 |
| 2024-02-22 | 7.1 | 2023-12-15 | 35.2 |
| 2024-02-21 | 7.2 | 2023-12-14 | 35.0 |
Innoviva Inc (INVA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Innoviva Inc
NAICS : 325412
SIC : 2834
ISIN : US45781M1018
Share Class Description:
INVA: Ordinary SharesDescription
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers